Emphysematous lung sclerosis
Otto, H.
Pneumologie 45(6): 476-478
1991
ISSN/ISBN: 0934-8387 PMID: 1924219 Document Number: 380084
Document emailed within 1 workday
Related Documents
Mahler, D.A.; D'Esopo, N.D. 1981: Peri-emphysematous lung infection Clinics in Chest Medicine 2(1): 51-57Bhadada, S.; Reddy, K.S.S.; Bhansali, A.; Dutta, P.; Sridhar, C.; Khandelwal, N. 2005: Co-occurrence of emphysematous cystitis and emphysematous myositis in type 2 diabetes Journal of the Association of Physicians of India 53: 821-823
Watanabe, H.; Kuroda, Y.; Oashi, H.; Yamamoto, K.; Fukaya, G. 1974: Surgical cases of cystic and emphysematous diseases of the lung in children Nihon Kyobu Geka Gakkai 22(5): 455-456
Yamaguchi, K.; Soejima, K.; Matsubara, H.; Oguma, T.; Inoue, T.; Shimada, H.; Mori, M.; Suzuki, K.; Koda, E. 1997: Normal predicted values of CT indices reflect emphysematous alterations in the lung Nihon Kyobu Shikkan Gakkai Zasshi 35(10): 1060-1066
Teculescu, D.B.; Racoveanu, C.; Păcuraru, R. 1971: Alveolar nitrogen plateau in "bronchitic" and "emphysematous" obstructive lung disease Scandinavian Journal of Respiratory Diseases 52(4): 199-211
Colombo, C.; Steinetz, B.G. 1975: Lung enzymes in emphysematous rats: effects of progestagens, antiphlogistics and metabolic inhibitors Archives Internationales de Pharmacodynamie et de Therapie 216(1): 86-96
van der Kamp, R.; Tak, P.P.; Jansen, H.M.; Bresser, P. 2007: Interstitial lung disease as the first manifestation of systemic sclerosis Netherlands Journal of Medicine 65(10): 390-394
Kuhara, H.; Wakabayashi, T.; Kishimoto, H.; Yanagi, T. 1980: An autopsy case of "respirator lung" with amyotrophic lateral sclerosis Nihon Kyobu Shikkan Gakkai Zasshi 18(6): 381-386
Ullman, S.; Halberg, P.; Wiik, A.; Jacobsen, S. 1999: Scleroderma--systemic sclerosis. Serology, lung function and survival Ugeskrift for Laeger 161(21): 3084-3090
Dziecioł, J.; Nowak, H.F.; Kemona, A.; Sulik, M.; Sulkowski, S. 1989: Sclerosis and fibrosis of the bone marrow in lung and gastrointestinal tract cancers Patologia Polska 40(2): 187-195
Corrado, A.; Neve, A.; Costantino, E.; Palladino, G.P.; Foschino Barbaro, M.P.; Cantatore, F.P. 2013: Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis Minerva Medica 104(5): 505-517
Gatta, G.; Di Grezia, G.; Iacomino, A.; Russo, A.; Petrillo, M.; Feragalli, B.; Ferragalli, B.; Cappabianca, S.; Grassi, R. 2013: HRCT in systemic sclerosis: correlation between respiratory functional indexes and extension of lung failure Journal of Biological Regulators and Homeostatic Agents 27(2): 579-587
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Ariani, A.; Lumetti, F.; Silva, M.; Santilli, D.; Mozzani, F.; Lucchini, G.; Delsante, G.; Sverzellati, N. 2014: Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative computed tomography assessments Journal of Biological Regulators and Homeostatic Agents 28(3): 507-513
Airò, P.; Danieli, E.; Rossi, M.; Frassi, M.; Cavazzana, I.; Scarsi, M.; Grottolo, A.; Franceschini, F.; Zambruni, A. 2007: Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase Clinical and Experimental Rheumatology 25(2): 293-296
Wangkaew, S.; Euathrongchit, J.; Patiwetwitoon, S.; Prasertwitayakij, N.; Kasitanon, N.; Louthrenoo, W. 2014: The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease Journal of the Medical Association of Thailand 97(8): 878-885
Chow, S.; Pope, J.E.; Mehta, S. 2008: Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension Clinical and Experimental Rheumatology 26(6): 1012-1017
Wodkowski, M.; Hudson, M.; Proudman, S.; Walker, J.; Stevens, W.; Nikpour, M.; Assassi, S.; Mayes, M.D.; Wang, M.; Baron, M.; Fritzler, M.J.; Pope, J.; Baron, M.; Markland, J.; Robinson, D.; Jones, N.; Khalidi, N.; Docherty, P.; Kaminska, E.; Masetto, A.; Sutton, E.; Mathieu, J-P.; Hudson, M.; Ligier, S.; Grodzicky, T.; LeClercq, S.; Thorne, C.; Gyger, G.; Smith, D.; Fortin, P.R.; Larché, M.; Rodriguez-Reyna, T.S.; Cabral, A.R.; Fritzler, M.J.; Hill, C.; Lester, S.; Nash, P.; Nikpour, M.; Roddy, J.; Patterson, K.; Proudman, S.; Rischmueller, M.; Sahhar, J.; Stevens, W.; Walker, J.; Zochling, J.; Assassi, S.; Mayes, M.D.; McNearney, T.A.; Salazar, G. 2015: Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival Clinical and Experimental Rheumatology 33(4 Suppl. 91): S131-S135
Turabián, J.L.; Moreiras Jiménez, J.L.; Marcos Sánchez, F.; de Lorenzo-Cáceres, A.; Durán Pérez-Navarro, A. 1984: Emphysematous pyelonephritis Medicina Clinica 82(4): 182
Kinnear, W.J.; Tattersfield, A.E. 1990: Emphysematous bullae Bmj 300(6719): 208-209